Acinetobacter calcoaceticus-Acinetobacter baumannii complex species in clinical specimens in Singapore

Epidemiology and Infection

Volumn 140, Issue 3, 2012, Pages 535-538

  Koh, T H ^a,b   Tan, T T ^a   Khoo, C T ^a   Ng, S Y ^c   Tan, T Y ^c   Hsu, L Y ^b   Ooi, E E ^d   Van Der Reijden, T J K ^e   Dijkshoorn, L ^e  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^c CHANGI GENERAL HOSPITAL   (Singapore)

^d DUKE NUS MEDICAL SCHOOL   (Singapore)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antibiotic resistance; bacterial infections; bacterial typing; hospital microbiology; molecular epidemiology

Indexed keywords

AMIKACIN; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; SULTAMICILLIN; TIGECYCLINE;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ACINETOBACTER NOSOCOMIALIS; ACINETOBACTER PITTII; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLAIMP LIKE GENE; BLAOXA 23 LIKE GENE; BLAOXA 58 LIKE GENE; GEOGRAPHIC DISTRIBUTION; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NONHUMAN; PREVALENCE; SINGAPORE;

ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ACINETOBACTER INFECTIONS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CLUSTER ANALYSIS; CROSS INFECTION; HOSPITALS; HUMANS; MOLECULAR TYPING; PREVALENCE; SINGAPORE;

EID: 84856259398     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268811001129     Document Type: Article

References (19)

1. Nemec A, et al. Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU). Research in Microbiology 2011; 162: 393-404.
2. Chen TL, et al. Comparison of one-tube multiplex PCR, automated ribotyping and intergenic spacer (ITS) sequencing for rapid identification of Acinetobacter baumannii. Clinical Microbiology and Infection 2007; 3: 801-806.
3. Chang HC, et al. Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region. Journal of Clinical Microbiology 2005; 43: 632-639.
4. van den Broek PJ, et al. Endemic and epidemic Acinetobacter species in a university hospital: an 8-year survey. Journal of Clinical Microbiology 2009; 47: 3593-3599.
5. Koh TH, et al. IMP-4 and OXA b-lactamases in Acinetobacter baumannii from Singapore. Journal of Antimicrobial Chemotherapy 2007; 59: 627-632. (Pubitemid 47073394)
6. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; twentieth informational supplement. Document M100-S20. Wayne, PA: CLSI, 2010.
7. Higgins PG, Lehmann M, Seifert H. Inclusion of OXA-143 primers in a multiplex polymerase chain reaction (PCR) for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. International Journal of Antimicrobial Agents 2010; 35: 305.
8. Poirel L, Nordmann P. Genetic structures at the origin of acquisition and expression of the carbapenemhydrolyzing oxacillinase gene blaOXA-58 in Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy 2006; 50: 1442-1448.
9. Corvec S, et al. Genetics and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-23 in Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy 2007; 51: 1530-1533. (Pubitemid 46586845)
10. Ellington MJ, et al. Multiplex PCRfor rapid detection of genes encoding acquired metallo-b-lactamases. Journal of Antimicrobial Chemotherapy 2007; 59: 321-322. (Pubitemid 47072076)
11. Lee YT, et al. Differences in phenotypic and genotypic characteristics among imipenem-non-susceptible Acinetobacter isolates belonging to different genomic species in Taiwan. International Journal of Antimicrobial Agents 2009; 34: 580-584.
12. Turton JF, et al. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. Journal of Clinical Microbiology 2006; 44: 2974-2976. (Pubitemid 44228598)
13. Lee YT, et al. First identification of blaOXA-51-like in nonbaumannii Acinetobacter spp. Journal of Chemotherapy 2009; 21: 514-520.
14. Mugnier PD, et al. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerging Infectious Diseases 2010; 16: 35-40.
15. Di Popolo A, et al. Molecular epidemiological investigation of multidrug-resistant Acinetobacter baumannii strains in four Mediterranean countries with a multilocus sequence typing scheme. Clinical Microbiology and Infection 2011; 17: 197-201.
16. Boo TW, et al. Molecular characterization of carbapenem-resistant Acinetobacter species in an Irish university hospital: predominance of Acinetobacter genomic species 3. Journal of Medical Microbiology 2009; 58: 209-216.
17. Nemec A, et al. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II. Journal of Antimicrobial Chemotherapy 2008; 62: 484-489.
18. Fu Y, et al. Wide dissemination of OXA-23-producing carbapenem-resistant Acinetobacter baumannii clonal complex 22 in multiple cities of China. Journal of Antimicrobial Chemotherapy 2010; 65: 644-650.
19. Park YK, et al. A single clone of Acinetobacter baumannii, ST22, is responsible for high antimicrobial resistance rates of Acinetobacter spp. isolates that cause bacteremia and urinary tract infections in Korea. Microbial Drug Resistance 2010; 16: 143-149.